CJTJ, if Aytu were to go for Zolpi Europe, a re-rate would occur as it would be fair to assume they are doing well from their US deal... that may be the very valuable validation we need...
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025